Regulation of water homeostasis is of vital importance for all terrestrial organisms. In most mammals, the maintenance of water balance is strictly dependent on water excretion in the kidney, which is under the control of the antidiuretic hormone arginine vasopressin (AVP). In the kidney, AVP binds to the vasopressin type 2 receptor (V2R). The alteration of water balance and consequent disorders are closely correlated to the fine regulation of the vasopressin-aquaporin 2 (AQP2) axis in the last tract of the renal tubule, the collecting duct. Over the last 20years and currently, the vasopressin—AQP2 axis, via the V2R bridge, was been and is still today the hottest therapeutic target investigated for the treatment of water balance disorders. Therefore, in the last years, significant progress has been made in the discovery and development of vasopressin type 2 receptor (V2R) agonists and antagonists. In this chapter the recent insights on V2R agonists, antagonists and biased agonists are reported. In addition , new approaches and recent advances for the treatment of water balance disorders are discussed.

Ranieri, M., Di Mise, A., Tamma, G., Valenti, G. (2022). Vasopressin Type 2 Receptor Agonists and Antagonists. In T. Kenakin (a cura di), Comprehensive Pharmacology (pp. 656-669). Elsevier [10.1016/B978-0-12-820472-6.00148-1].

Vasopressin Type 2 Receptor Agonists and Antagonists

Di Mise A.;
2022

Abstract

Regulation of water homeostasis is of vital importance for all terrestrial organisms. In most mammals, the maintenance of water balance is strictly dependent on water excretion in the kidney, which is under the control of the antidiuretic hormone arginine vasopressin (AVP). In the kidney, AVP binds to the vasopressin type 2 receptor (V2R). The alteration of water balance and consequent disorders are closely correlated to the fine regulation of the vasopressin-aquaporin 2 (AQP2) axis in the last tract of the renal tubule, the collecting duct. Over the last 20years and currently, the vasopressin—AQP2 axis, via the V2R bridge, was been and is still today the hottest therapeutic target investigated for the treatment of water balance disorders. Therefore, in the last years, significant progress has been made in the discovery and development of vasopressin type 2 receptor (V2R) agonists and antagonists. In this chapter the recent insights on V2R agonists, antagonists and biased agonists are reported. In addition , new approaches and recent advances for the treatment of water balance disorders are discussed.
Capitolo o saggio
Aquaporin 2; Kidney disorders; V2R agonists; V2R antagonists; Vasopressin; Water imbalance;
English
Comprehensive Pharmacology
Kenakin, T
2022
9780128208762
4
Elsevier
656
669
Ranieri, M., Di Mise, A., Tamma, G., Valenti, G. (2022). Vasopressin Type 2 Receptor Agonists and Antagonists. In T. Kenakin (a cura di), Comprehensive Pharmacology (pp. 656-669). Elsevier [10.1016/B978-0-12-820472-6.00148-1].
reserved
File in questo prodotto:
File Dimensione Formato  
Ranieri-2022-Comprehensive Pharmacology-VoR.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 1.62 MB
Formato Adobe PDF
1.62 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/515124
Citazioni
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
Social impact